Their results suggested that short-term antibody-mediated inhibition of CTLA-4 accelerates the progression of atherosclerosis by inducing T cells to drive an inflammatory response, resulting in the formation of plaques with larger necrotic cores and less collagen (69). Here, CTLA4 is linked to atherosclerosis.